Polyethylenimine ( PEI ) derivatives are potent polycationic nonviral vectors for gene transfer. The gene transfer efficiency of glucosylated and galactosylated PEI derivatives was optimized using green fluorescent protein gene as reporter gene in FaDu and PANC3 human carcinoma cell lines. Glucosylated or galactosylated PEI derivatives were found to be slightly less cytotoxic than unsubstituted PEI. Gene transfer efficiency was found to be related to DNA / cell number ratio and optimal gene transfer efficiency was achieved at 4 g DNA / 10 5 cells. PEI ± DNA complexes were found to enter cells rapidly and were detected into cytoplasmic vesicles 2 hours post -transfection. Green fluorescent protein gene expression was detected 4 ± 6 hours after transfection and reached maximal value 24 hours post -transfection. The results achieved demonstrated that glucosylated PEI yield higher and longer gene transfer efficiency than unsubstituted PEI. Using glucosylated PEI allowed to achieve significant gene transfer in more than 10% of the total cell population for more than 4 days. These data were then applied to p53 gene transfer in PANC3 cells bearing p53 gene deletion and consequently unable to initiate apoptosis. Using glucosylated PEI, p53 gene transfer was successfully achieved with subsequent recovery of p53 mRNA expression and transient P53 protein expression. P53 protein functionality was further demonstrated because transfected cells underwent apoptosis. Cancer Gene Therapy ( 2001 ) 8, 203 ± 210
C arcinogenesis is frequently associated with early gene alterations inducing functional abnormalities of protein controlling cell proliferation. In many cancers, p53 tumor suppressor gene is known to be mutated in a majority of the cases. 1 Despite powerful conventional cancer treatment including surgery, radiotherapy, and chemotherapy, treatment failures often appear after general dissemination of the disease, local recurrence or second tumor generation within the same area. In that context, reversion of early carcinogenesis factors by gene transfer was proposed to allow destruction of early cancer clones. When combined with conventional therapies, induction of suppressor genes such as p53 could ameliorate local control of the disease. In most cases, gene transfer was assessed by using viral vectors. Enhanced gene transfer efficiency was already reported when targeted vectors were used directed against specific cell surface protein such as carbohydrate binding proteins, 2 which are often altered during carcinogenesis. 3 In head and neck cancer, several studies reported wild -type p53 gene transfer in vitro and in vivo in different tumor models in which transfected cells underwent spontaneous apoptosis. 4 ± 6 Encouraging results have been reported when wild -type p53 gene transfer was associated with conventional therapy, radiotherapy, 7, 8 or chemotherapy 9 and resulted in enhanced apoptosis induction. Wild -type p53 gene transfer was also evaluated in phase I clinical trial and gave satisfactory results with tumor regression. 10 In pancreas cancer, adenovirus -mediated wild -type p53 gene transfer has been reported 11, 12 with consequent apoptosis induction in vitro and in vivo.
Alternative gene transfer technologies based on nonviral vectors have been proposed. Polyethylenimine ( PEI ) derivatives are polycationic molecules 13 that are able to form stable complexes with plasmidic DNA.
14 PEI ± DNA complexes attach to the cell surface, migrate into clumps that enter the cell by endocytosis and are deaggregated in acidic lysosomal compartment, 15 and /or enter the nucleus. 16, 17 PEI derivatives can be proposed as linear (22 kDa ) or reticulated ( 25 kDa ) molecules that proved efficient for gene transfer in vitro and in vivo. 18, 19 Glycosyl -substituted PEI derivatives have several potential interests. Glucosylated PEI increased the hydrophilicity and enhanced gene transfer efficiency through decreased size 20 and aggregation of PEI ± DNA complexes. 21 Galactosylated PEI derivatives have been synthesized to enhance interactions with cell membranes through carbohydrate binding protein recognition and specifically target PEI ± DNA complexes toward biological systems that express galectins. 22 Galectin expression was already reported in some head and neck tumor cells 23 ± 25 and in such cases could therefore influence the interaction of galactosylated PEI ± DNA complexes with cell membranes. Increased gene transfer efficiency has already been reported 26 using glycosylated polylysines as nonviral vectors showing that polylysines bearing glucose or galactose residues were the most efficient in transfecting cells.
This in vitro study was designed to evaluate and compare green fluorescent protein (GFP ) gene transfer efficiency of glycosylated (glucosylated and galactosylated ) PEI derivatives, then to apply the optimized transfer protocol to wildtype p53 gene transfer in p53-deleted tumor cell line.
MATERIALS AND METHODS

Cell lines
FaDu pharynx carcinoma cell line was kindly received from Prof. A. Hanauske ( Munich University, Germany ) and PANC3 pancreas carcinoma and CAL51 breast carcinoma cell lines from Dr. J. L. Fischel ( Centre Antoine Lacassagne, Nice, France) as part of the exchange program of the European Organization for Research and Treatment of Cancer (EORTC ) Preclinical Therapeutic Models Group. All cell lines were cultured in phenol red -free RPMI 1640 medium supplemented with 10% heat -inactivated fetal calf serum in a 378C, 5% CO 2 atmosphere.
p53 status of the cell lines was previously characterized 27 by DNA sequencing. Point mutation (G to T transversion ) at codon 248 in exon 7, resulting in arginine to leucine substitution, was detected in FaDu cells. Internal sequence deletion corresponding to exons 2 to 4 was evidenced in PANC3 cells. Wild -type p53 status was found in CAL51 cell line. FaDu cell line was mainly used for the optimization of the experimental protocols, then optimized conditions were applied to PANC3 cell line. CAL51 cell line was used as wild -type p53 positive control.
PEI derivatives
Branched 25-kDa PEI ( PEI25 ) and linear 22 -kDa polyethylenimine ( PEI22 ) as well as tetraglucose (Glu4, Glc4Glc4Glc6Glc ), tetragalactose ( Gal4, Gal3Gal-4Gal3Gal ) , polymerized tetraglucose (PolyGlu4 ) , and polymerized tetragalactose ( PolyGal4 ) derivatives were obtained from Dr. P. Erbacher (Laboratoire de Chimie Ge Âne Âtique, Illkirch, France ) . For the tetraglucose and tetragalactose derivatives, PEI was glycosylated by reductive amination in the presence of sodium cyanoborohydride 28 and the level of substitution measured by using the resorcinol /sulfuric acid micromethod was 5%. For the polymerized linear glycosylated PEI derivatives, the two primary amines of the linear PEI were first modified with the heterobifunctional reagent succinimidyl 3 -(2 -pyridyldithio ) propionate (SPDP ) as previously described.
32 Dithiopyridine -derivatized PEI was then glycosylated ( modification level of 2% ) with the reductive amination procedure. The presence of sodium cyanoborohydride also reduces the dithiopyridine group into a thiol function. After the purification of the thiol-functionalized glycosylated -PEI derivatives by gel filtration on a Sephadex G -25 column, oxidation of the thiol groups polymerized the PEI derivatives through the formation of disulfide bridges yielding a linear copolymer ( type A -A n -A ) of the glycosylated -PEI derivatives. The degree of polymerization was estimated by size exclusion chromatography (Fig 1 ) on a 12Â500 mm Sepharose 2 CL -6B (Pharmacia Biotech, Uppsala, Sweden ) and was found to be 2± 4 (molecular weight ranging from 20 to 80 kDa ).
Plasmids pEGFP-C3 (Clontech , Montigny -Le-Bretonneux, France) and pNCNeo ( Dr. J.-M. Heard, Pasteur Institut, Paris, France) encoding, respectively, the GFP and the P53 protein under the control of the cytomegalovirus promoter were used in these experiments. Plasmids were purified from Escherichia coli using Jexstar MaxiPrep columns ( Quantum Probe, Montreuil s/bois, France ).
Cytotoxicity assays
Cytotoxicity assays were performed using ( 4,5-dimethylthiazol -2 -yl ) -2,5 -diphenyl -tetrazolium bromide ( MTT, Sigma, Saint -Quentin Fallavier, France) as previously described. 29 Briefly, cell suspensions containing 2.10 4 viable cells/mL were plated into 96 -well dishes and allowed to attach for 48 hours at 378C in a 5% CO 2 atmosphere. The culture medium was then removed and the cells were incubated for 2 hours at 378C in culture medium containing PEI or PEI ±DNA complexes. After this incubation period, the cells were washed twice with phosphate - buffered saline and allowed to grow for 48 hours in culture medium.
MTT ( final concentration 5 mol /L ) was then added into each well and the dishes were incubated for 3 hours at 378C to allow MTT metabolization into formazan crystals. The crystals were finally solubilized by adding 50 L of 25% sodium dodecyl sulfate ( SDS ) solution into each well. Blank control wells with no cells received also the same reagents. Absorbance was finally measured at 540 nm using a Multiskan MCC340 plate reader (Flow Laboratories, Les Ulis, France ). Absorbance of blank control was subtracted from the absorbance values in the other wells. Concentrations inhibiting 50% of cell growth (IC 50 ) were calculated using the median effect analysis algorithm. 30 
Cell transfection
Cells were seeded at the density of 5.10 4 cells / mL in 24 -well plates (Costar-Dutcher, Brumath, France ) 24 hours before transfection to reach 60± 70% confluence during transfection. All experiments were performed in triplicate. Amounts and volumes given below refer to a single well. Before transfection, cells were supplemented with fresh serum -free medium. Two micrograms of plasmid (pEGFP -C3 or pNCNeo ) and the corresponding amount of PEI were separately prepared, 31 vortexed gently and spun down to collect the entire volume of solution. PEI22 was used at five charge equivalents ( five amino groups for each phosphate group ) and PEI25 at 10 charge equivalents. 32 Three microliters of 10 mmol /L PEI solution was mixed with plasmid at once then, 5 minutes later, mixed, vortexed, and spun down. After approximately 15 minutes, 100 L of the resulting mixture was added to the cells and the cell supernatant was homogenized by a gentle horizontal hand rotation. After 2 hours, 50 L fetal calf serum was added. The cells were cultured for an additional 24-hour period and tested for GFP or p53 gene expression.
Intracellular localization of PEI ± DNA complexes
PEI ± DNA complexes were stained in 10 g /mL propidium iodide ( PI) solution before being incubated with the cells according to Godbey et al. 16 PEI ±DNA complexes were then localized in FaDu cells after transfection using fluorescence microscopy using an AX70 Provis epifluorescence microscope ( Olympus, Rungis, France ) fitted with a LH1600 cooled CCD camera (Lhesa, Cergy -Pontoise, France ). PI fluorescence was visualized through high numerical aperture (1.35 ), Â40 oil immersion plan apochromatic objective using excitation band -pass filter ( 460± 490 nm ) and emission high -pass filter ( > 560 nm ).
GFP expression analysis
GFP expression was evaluated using flow cytometry ( Orthocyte, Ortho Diagnostic Systems, Roissy, France ) on cell suspensions containing 10 6 cells /mL obtained after trypsinization ( trypsin ± EDTA, Life Technologies ) of multiwell dishes. GFP was excited at 488 nm and its fluorescence signal detected through a 510 ± 520 nm band -pass filter. Analyses were performed on at least 5000 cells and results expressed as percentage of cells expressing GFP.
Using the same cell suspensions, GFP expression was visualized using epifluorescence microscopy ( AX70 Provis microscope, Olympus ). Filter sets used for visualization of GFP were 460 ±490 nm band -pass excitation filter, 505 -nm dichroic mirror and 510± 550 nm band -pass barrier filter.
p53 gene expression analysis p53 mRNA and protein expression were analyzed 24 hours after transfection using RT-PCR and Western blot analysis in PANC3 cell line. Cell extracts were prepared after collection of both trypsinized ( trypsin ± EDTA ) adhesive cells and cells detached from the culture support collected by centrifugation ( 300Âg, 10 minutes ). Reverse transcriptase polymerase chain reaction. Isolation of total RNA was performed using TRIzol 1 and according to the manufacturer's specifications ( Life Technologies, Cergy, Pontoise, France ) . cDNA synthesis was performed with 1 g total RNA in a reaction volume of 20 L containing 100 ng of random primers, 50 mmol/L Tris ± HCl, pH 8. H -TCT GTG ACT TGC ACG TAC TC -3 H (sense ) and 5 H -CAC GGA TCT GAA GGG TGA AA -3 H (antisense ). 33 The PCR tubes were incubated for p53 cDNA amplification, as follows: the first cycle was 5 minutes at 958C, 1 minute at 578C, and 1 minute at 728C. The 33 following cycles were 1 minute at 948C, 1 minute at 578C, and 1 minute at 728C. After completion of the PCR cycles, the mixture was finally incubated for 7 minutes at 728C. p53 PCR products were electrophoretised on 1% agarose gel containing 0.1 g /mL of ethidium bromide (EB ) and analyzed by UV transillumination using a Gel Doc 1000 system ( Bio Rad, Ivry -sur-Seine, France ) . Western blot analysis. Western blots were performed using cell extracts prepared in ice -cold lysis buffer ( 20 mmol /L Tris ± HCl pH 8.0, 100 mmol / L NaCl, 1% Triton X -100, 0.5% sodium -deoxycholate, 0.1% SDS, 1 mmol / L sodium -EDTA ). Samples were incubated for 30 minutes on ice then stored at À 808C until analyzed. Defrosted samples received 20 g of protein in Laemmli buffer (Bio -Rad ) then boiled for 5 minutes, subjected to 10% SDS -polyacrylamide gel electrophoresis (PAGE ) and were transferred onto Immobilon-P transfer membranes (Millipore, St Quentin Yvelines, France ), using semidry blotting techniques. Membranes were probed for 1 hour with DO -7 mouse P53 primary monoclonal antibody (Dako, Trappes, France ) and then probed with horseradish peroxidase secondary antibody for 1 hour at room temperature. Immunological complexes were visualized by chemiluminescence detection according to the manufacturer's recommendations ( Amersham -Pharmacia Biotech, Orsay, France ).
Determination of apoptosis
Acridine orange (AO ) ±EB double -labeling protocol, allowing the simultaneous discrimination of viable, necrotic, and apoptotic cells was adapted from Olivier. 34 Adhesive cells were collected after trypsinization (trypsin ± EDTA ) . Cells detached from the culture support were collected by centrifugation (300Âg for 10 minutes ) . Cell suspensions containing 10 6 cells were stained in phosphate -buffered saline by a solution containing 0.03 g/ mL AO and 10 g/ ml EB then analyzed using flow cytometry (Orthocyte flow cytometer, Ortho Diagnostic Systems ). The green fluorescence of AO (FL1 ) was collected through a 530 15-nm band -pass filter and the red fluorescence (FL2 ) of EB was collected through a 575 -nm dichroic filter. Logarithmic amplification and fluorescence compensation ( FL2 ±FL1: 30% ) were employed to monitor AO and EB fluorescence signals.
Statistical analysis
Student's t test was employed to determine the statistical significance with a limit set to P <.05 using Statview 4.02 software (Abacus Concepts, Berkeley, CA ) .
RESULTS
Cytotoxicity of PEI derivatives and PEI ± DNA complexes
No significant cytotoxicity was observed in FaDu cell line exposed for 24 hours to either PEI derivatives or PEI ±DNA complexes (GFP plasmid ) with more than 95% viable cells ( 96 20% ) as detected using MTT assay. PEI22 was found to be slightly more cytotoxic than the other derivatives with IC50 of 35 14 and 62 17 mmol /L, respectively for PEI22 and PEI22± DNA complexes. In each of the cases, the IC50 values were above the highest evaluated concentration ( 100 mmol /L ) .
Transfection of GFP in FaDu cell line
Using the standard procedure (4 g DNA / well containing 10 5 cells), GFP transfer efficiency was evaluated using flow cytometry after 24 hours for all PEI derivatives ( PEI25, PEI22, Glu4, PolyGlu4, Gal4, PolyGal4 ) . The fraction of GFP -expressing cells was found to vary dramatically with the nature of PEI derivative ( Table 1) . The transfer efficiency was found to be significantly higher with PEI22 than with PEI25 ( P <.01 ). Among glycosylated derivatives, gene transfer efficiency was found to be significantly higher (P < .001) for glucosylated (Glu4 and PolyGlu4 ) than for galactosylated derivatives (Gal4 and PolyGal4 ) . Galactosylated derivatives yielded significantly lower transfer efficiency ( P <.01 ) than unsubstituted PEI22. Among glucosylated derivatives, Glu4 yielded significantly (P < .02) higher transfer efficiency than PolyGlu4. Considering these results, we then attempted to further increase GFP gene transfer efficiency using glucosylated PEI derivatives by increasing DNA amount loaded per culture well containing 10 5 cells. Within the concentration range tested (2 ±16 g DNA /10
5 cells ) GFP expression was found to be directly influenced by DNA amount ( Fig 2) . Whatever the PEI derivative used, gene transfer efficiency was found to reach a maximal value at 4 g DNA /10
5 cells then to decrease further with increasing concentration. In every independent experiment, Glu4 was found to yield the highest transfer efficiency.
Using the above -mentioned experimental conditions, expression of GFP after transfection was followed during 144 hours ( Fig 3 ) . For the three PEI derivatives tested ( PEI22, Glu4, and PolyGlu4 ) , maximal expression was reached 24 hours after transfection. No difference in GFP expression kinetic profile was observed between the three compounds. Here again, Glu4 yielded the highest transfer efficiency with approximately 20% GFP expressing cells at 24 hours ( Fig 4A ) and PEI22 the lowest with approximately 6%. Using Glu4, GFP gene expression was detected in 3 ±4% of the total cell population, 4± 6 hours after transfection (data not shown) and was maintained in more than 10% of the cell population for more than 96 hours. Using PolyGlu4, this level was maintained far less than 24 hours, and was never reached with PEI22.
Intracellular localization of glucosylated PEI complexes in FaDu cells
Twenty minutes after transfection, Glu4 PEI ± DNA complexes were localized in the extracellular medium because no fluorescence was observed after washing of the cell Results are the mean fraction of GFP -expressing cells ( SD ) as determined from triplicate flow cytometry experiments. MERLIN, DOLIVET, DUBESSY, ET AL: NONVIRAL P53 GENE TRANSFER USING GLUCOSYLATED PEI monolayer ( data not shown ). Two hours after transfection, PEI ± DNA complexes were found to be localized in the cytoplasm of FaDu cells ( Fig 5A ) probably in endosomes. Twenty-four hours after transfection, PEI ± DNA complexes were mainly localized at the perinuclear level (Fig 5B ) . At this time, GFP expression was visualized as perinuclear homogenous green fluorescence ( Fig 5C ) .
Transfection of GFP and p53 in PANC3 cell line using glucosylated PEI
As observed in FaDu cell line, GFP transfer efficiency in PANC3 cell line was found to be directly influenced by the presence of glycosylated residues (Table 2 ) . Again, GFP transfer efficiency was higher for glucosylated PEI derivatives (Glu4 and PolyGlu4 ) than with unsubstituted PEI ( PEI22 ), the highest efficiency being achieved with Glu4 ( Fig 4B) . Transfection of p53 gene was performed using the same experimental protocol as used for GFP except for the plasmid, which was changed to pNCNeo as described in Materials and Methods.
After being transfected, p53 mRNA expression was detected in PANC3 cells whether using PEI22, Glu4, or PolyGlu4 as vector ( Fig 6) whereas no p53 mRNA expression was detected in control untransfected cells.
These data were confirmed as P53 protein expression was analyzed. A low but significant level ( signal -to -background -noise ratio > 3 ) of basal P53 expression was detected in p53 -transfected PANC3 cells ( Fig 7 ) .
Apoptosis induction following p53 gene transfer
This was evaluated using flow cytometry with AO ±EB double labeling (Fig 8) . P53 functionality was demonstrated through a significant induction of apoptosis in PANC3 cells as opposed to untreated controls. In addition, significantly ( P <.001 ) higher apoptosis induction rates were observed when glucosylated PEI derivatives ( Glu4, PolyGlu4 ) were used (Table 3 ) , compared with unsubstituted PEI (PEI22) . No significant difference in apoptosis induction was observed between Glu4 and PolyGlu4. Higher necrosis cell fraction was detected in cells exposed to Glu4 (7.3 2.2% ) or PolyGlu4 (6.2 1.9% ) compared to untreated controls ( 3.4 2.4%) or PEI22 ( 4.2 1.8% ), probably related to postapoptosis events. No difference in the necrotic cell fraction was observed when the cells were exposed to Glu4 or PolyGlu4.
DISCUSSION
Because p53 mutations are early events in carcinogenesis, numerous attempts have been reported to restore wild -type p53 status in tumor cells by means of gene transfer in vitro and in vivo.
4 ± 6 Viral vectors and especially adenovirus vector are mainly used. Adenovirus -mediated gene transfer efficiency are limited in vivo by induction of immune response and /or in vitro lack of expression of receptors involved in the internalization of the transgene. 35 Even if viruses remain the most used vectors, nonviral vectors appear to offer advantages such as the lack of immune response, and therefore, their use is constantly increasing. The main disadvantage of nonviral vectors is the low efficiency for gene transfer and the lack of targeting properties. Among nonviral vectors for gene transfer, polycationic derivatives were reported to be interesting vectors and recently their efficiency has been reported to be increased by addition of sugar residues. 26 PEI derivatives are nonviral vectors whose efficiency for gene transfer has been established. 15 Recently, glycosylated derivatives have been evaluated in view of improving some physicochemical properties such as solubility, aggregation, 20, 21 and /or increasing their specificity by targeting lectins such as galectins, 22 which are frequently overexpressed at the surface of tumor cells. 3 This paper was dedicated to the study of glucose -or galactose-substituted -PEI derivatives in view of gene transfer in head and neck (FaDu ) and pancreas ( PANC3) tumor cells. Cytotoxicity assays first revealed that either unsubstituted or glycosylated -PEI derivatives complexed with DNA are devoid of intrinsic cytotoxicity. Using the GFP gene as reporter gene to evaluate gene transfer efficiency in FaDu and PANC3 cells, the results achieved in both cell lines showed that PEI derivatives can be considered as highly efficient nonviral vector for delivering plasmids in vitro, thus confirming previous results obtained with luciferase as reporter gene. 13 Gene transfer efficiency was found to be related to DNA / cell number ratio and optimal gene transfer efficiency was achieved with 4 g DNA /10
5 cells. Glucosylated PEI derivatives entered FaDu cells rapidly because vesicular fluorescence of propidium iodide± labeled PEI ± DNA complexes was detected inside the cytoplasm as early as 2 hours post -transfection and then reached perinuclear localization ( not shown) . These data are consistent with the fact that, as opposed to cationic lipids, PEI was reported to be able to enhance transgene expression when complexes were microinjected into the cytoplasm of cultured cells, and therefore, PEI promotes gene delivery from the cytoplasm in the nucleus and that transgene expression in the nucleus is prevented by complexation with cationic lipids but not with cationic polymers. 17 Using flow cytometry, GFP gene expression was detected 4± 6 hours after transfection. These data are consistent with data of Godbey et al 16 in hybridoma cells using unsubstituted PEI. They reported that PEI entered cells within 3± 4 hours post -transfection and reporter gene expression was observed using fluorescence microscopy as soon as 1 hour post -transfection.
In both cell lines, GFP gene transfer efficiency was significantly increased by using glucosylated PEI derivatives compared to unsubstituted PEI. The gene transfer efficiency achieved using glucosylated PEI can be considered as very satisfactory compared to data achieved in various cell lines with unsubstituted PEI or Transfectam.
14 Furthermore, glucosylated PEI was found to maintain significant gene transfer for up to 4 days. In FaDu cell line, glucosylated PEI derivatives yielded significant higher gene transfer efficiency than galactosylated derivatives, which may indicate that FaDu cells are not overexpressing galectins. Enhanced gene transfer efficiency of glucosylated PEI derivatives may be explained by enhanced intracellular trafficking of glycoplexes by intracellular sugar receptors, as already suggested with glycosylated polylysines. 26 This was also observed in PANC3 cells where GFP gene transfer efficiency using glucosylated PEI was significantly higher than with unsubstituted PEI.
PANC3 cells were then used as model for evaluation of wild -type p53 gene transfer. This cell line appears as a good model because PANC3 cells are p53 -deleted and lack p53 gene transcription and translation. 28 Considering wild -type p53 gene transfer, the results achieved in PANC3 cells were fully consistent with those achieved with GFP and further confirmed the higher efficiency of glycosylated-PEI derivatives compared to unsubstituted PEI. Wild -type p53 was successfully transcribed into p53 mRNA and translated into functional P53 protein. P53 protein functionality was evidenced through the low level of expression observed suggesting short protein half -life, which characterizes wildtype P53 protein, and the significant spontaneous induction of apoptosis as already observed in experiments using viral vectors. 4 In conclusion, PEI derivatives are potent nonviral vectors for gene transfer into human cancer cell lines and may represent an interesting alternative to viral vectors. Glucosylated PEI derivatives can confer physicochemical and biological advantages that further justify their interest by reaching high and long -lasting transgene expression. Because PEI was reported to be potent in vivo, 13 experiments on human tumor xenografted mice are on-going to evaluate the potential interest of p53 gene transfer using glycosylated PEI derivatives.
